Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | UCB4594 |
Synonyms | |
Therapy Description |
UCB4594 is a humanized IgG1 antibody that targets human leukocyte antigen-G (HLA-G), which potentially increases antitumor immune activity (Immuno-Oncology and Technology (2023), 20 (Supplement)). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
UCB4594 | UCB-4594|UCB 4594 | UCB4594 is a humanized IgG1 antibody that targets human leukocyte antigen-G (HLA-G), which potentially increases antitumor immune activity (Immuno-Oncology and Technology (2023), 20 (Supplement)). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06380816 | Phase Ib/II | UCB4594 | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer | Recruiting | GBR | 0 |